Structural reorganization of the interleukin-7 signaling complex

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 7, 2012, Pages 2503-2508

  McElroy, Craig A ^a   Holland, Paul J ^b   Zhao, Peng ^c   Lim, Jae Min ^c   Wells, Lance ^c   Eisenstein, Edward ^b,d   Walsh, Scott T R ^b,d  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

Biophysics; Cancer mutations; Homodimerization; X ray crystallography

Indexed keywords

HOMODIMER; INTERLEUKIN 7 RECEPTOR ALPHA; TERNARY COMPLEX FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; BIOPHYSICS; CD4+ T LYMPHOCYTE; CELL SURFACE; CRYSTAL STRUCTURE; GAIN OF FUNCTION MUTATION; HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; T LYMPHOCYTE;

DIMERIZATION; INTERLEUKIN-7; LIGANDS; PROTEIN BINDING; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION; X-RAY DIFFRACTION;

EID: 84857131673     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1116582109     Document Type: Article

References (40)

1. Mazzucchelli R, Durum SK (2007) Interleukin-7 receptor expression: Intelligent design. Nat Rev Immunol 7(2):144-154. (Pubitemid 46178275)
2. Ozaki K, Leonard WJ (2002) Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem 277:29355-29358. (Pubitemid 41079217)
3. Kovanen PE, Leonard WJ (2004) Cytokines and immunodeficiency diseases: Critical roles of the γ(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol Rev 202(1):67-83. (Pubitemid 39576905)
4. Watanabe M, et al. (1998) Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J Exp Med 187: 389-402. (Pubitemid 28080068)
5. Gregory SG, et al.; Multiple Sclerosis Genetics Group (2007) Interleukin 7 receptor αchain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 39:1083-1091. (Pubitemid 47340652)
6. Hafler DA, et al.; International Multiple Sclerosis Genetics Consortium (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357: 851-862. (Pubitemid 47347319)
7. Barata JT, Cardoso AA, Nadler LM, Boussiotis VA (2001) Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by downregulating the cyclin-dependent kinase inhibitor p27(kip1). Blood 98:1524-1531.
8. Zenatti PP, et al. (2011) Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia. Nat Genet 43:932-939.
9. Rochman Y, Spolski R, Leonard WJ (2009) New insights into the regulation of T cells by γ(c) family cytokines. Nat Rev Immunol 9:480-490.
10. Goodwin RG, et al. (1990) Cloning of the human and murine interleukin-7 receptors: Demonstration of a soluble form and homology to a new receptor superfamily. Cell 60:941-951.
11. Wells JA (1996) Binding in the growth hormone receptor complex. Proc Natl Acad Sci USA 93(1):1-6.
12. Rose T, Lambotte O, Pallier C, Delfraissy JF, Colle JH (2009) Identification and biochemical characterization of human plasma soluble IL-7R: Lower concentrations in HIV-1-infected patients. J Immunol 182:7389-7397.
13. Rose T, et al. (2010) Interleukin-7 compartmentalizes its receptor signaling complex to initiate CD4 T lymphocyte response. J Biol Chem 285:14898-14908.
14. Pillet AH, et al. (2010) IL-2 induces conformational changes in its preassembled receptor core, which then migrates in lipid raft and binds to the cytoskeleton meshwork. J Mol Biol 403:671-692.
15. Kammer W, et al. (1996) Homodimerization of interleukin-4 receptor α chain can induce intracellular signaling. J Biol Chem 271:23634-23637.
16. Malka Y, et al. (2008) Ligand-independent homomeric and heteromeric complexes between interleukin-2 or -9 receptor subunits and the γ chain. J Biol Chem 283: 33569-33577.
17. Yoshimura A, Longmore G, Lodish HF (1990) Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature 348:647-649. (Pubitemid 120015129)
18. Schreiber G, Walter MR (2010) Cytokine-receptor interactions as drug targets. Curr Opin Chem Biol 14:511-519.
19. McElroy CA, Dohm JA, Walsh ST (2009) Structural and biophysical studies of the human IL-7/IL-7Rα complex. Structure 17:54-65.
20. Wang X, Rickert M, Garcia KC (2005) Structure of the quaternary complex of interleukin-2 with its α, β, and γc receptors. Science 310:1159-1163. (Pubitemid 41681737)
21. Livnah O, et al. (1999) Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283:987-990.
22. Hage T, Sebald W, Reinemer P (1999) Crystal structure of the interleukin-4/receptor αchain complex reveals a mosaic binding interface. Cell 97:271-281. (Pubitemid 29194277)
23. LaPorte SL, et al. (2008) Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 132:259-272. (Pubitemid 351172435)
24. Wickham J, Jr., Walsh ST (2007) Crystallization and preliminary X-ray diffraction of human interleukin-7 bound to unglycosylated and glycosylated forms of its α-receptor. Acta Crystallogr Sect F Struct Biol Cryst Commun 63:865-869.
25. Wang X, Lupardus P, Laporte SL, Garcia KC (2009) Structural biology of shared cytokine receptors. Annu Rev Immunol 27:29-60.
26. Rose T, Moreau JL, Eckenberg R, Thèze J (2003) Structural analysis and modeling of a synthetic interleukin-2 mimetic and its interleukin-2Rβ2 receptor. J Biol Chem 278: 22868-22876. (Pubitemid 36830350)
27. Pillet AH, et al. (2008) Human IL-Rβ chains form IL-2 binding homodimers. Eur Cytokine Netw 19(1):49-59.
28. Deivanayagam CC, et al. (2000) Novel fold and assembly of the repetitive B region of the Staphylococcus aureus collagen-binding surface protein. Structure 8(1):67-78. (Pubitemid 30051343)
29. Stauber DJ, et al. (2006) Crystal structure of the IL-2 signaling complex: Paradigm for a heterotrimeric cytokine receptor. Proc Natl Acad Sci USA 103:2788-2793.
30. Brown RJ, et al. (2005) Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat Struct Mol Biol 12:814-821. (Pubitemid 43086257)
31. Remy I, Wilson IA, Michnick SW (1999) Erythropoietin receptor activation by a ligand-induced conformation change. Science 283:990-993.
32. Shochat C, et al. (2011) Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias. J Exp Med 208:901-908.
33. Senes A, et al. (2007) E(z), a depth-dependent potential for assessing the energies of insertion of amino acid side-chains into membranes: Derivation and applications to determining the orientation of transmembrane and interfacial helices. J Mol Biol 366: 436-448. (Pubitemid 46136195)
34. Yoda A, et al. (2010) Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA 107:252-257.
35. Constantinescu SN, et al. (2001) Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain. Proc Natl Acad Sci USA 98:4379-4384. (Pubitemid 32294985)
36. Lu X, Gross AW, Lodish HF (2006) Active conformation of the erythropoietin receptor: Random and cysteine-scanning mutagenesis of the extracellular juxtamembrane and transmembrane domains. J Biol Chem 281:7002-7011. (Pubitemid 43847463)
37. Lemmon MA, Schlessinger J (2010) Cell signaling by receptor tyrosine kinases. Cell 141:1117-1134.
38. Philo JS, Aoki KH, Arakawa T, Narhi LO, Wen J (1996) Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: One high-affinity and one lowaffinity interaction. Biochemistry 35:1681-1691. (Pubitemid 26055303)
39. DeLano W (2002) The PyMOL Molecular Graphics System (DeLano Scientific, San Carlos, CA).
40. Brünger AT, et al. (1998) Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54: 905-921.